IL1A and systemic sclerosis: Increased levels of circulating IL-1 (cancer-promoting), IL-2, IL-2 receptors (IL-2R) (cancer-suppressive), IL-4, IL-8, IL-17 (cancer-promoting) and TNF-α have been reported in patients with SSc [75,76,77,78].